Global E-Pharma Market Poised for Significant Growth, Expected to Reach US$133.369 Billion by 2030
February 14, 2025 08:11 ET
|
Research and Markets
Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "E-Pharma Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The e-pharma market is undergoing...
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
February 13, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
February 13, 2025 07:00 ET
|
Nutriband Inc.
Partnership Agreement
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
February 11, 2025 09:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
February 11, 2025 09:00 ET
|
Nutriband Inc.
ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European...
Pharmaceutical Suppositories Market to Reach $3.2 billion, Globally, by 2035 at 5.7% CAGR: Allied Market Research
February 07, 2025 10:18 ET
|
Allied Market Research INC
Wilmington, Delaware , Feb. 07, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Pharmaceutical Suppositories Market by Type (Rectal Suppositories, Vaginal...
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
February 07, 2025 08:45 ET
|
Nutriband Inc.
U.S. Patent Office issues Notice of Allowance for new patent covering Nutriband's AVERSA™ technology
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
February 07, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
North Texas Took Center Stage at Advanced Therapies Week 2025, Highlighting Innovation and Collaboration in Life Sciences
February 06, 2025 10:00 ET
|
BioNTX
DALLAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- From January 20-23, 2025, North Texas took center stage as a global hub for innovation during Advanced Therapies Week (ATW) 2025. This signature event...
Middle East & Africa Pharmaceuticals Market Report 2025: Presents Country-Level Growth Trends and Shares to 2030 - Julphar (Gulf Pharmaceutical), Bayer Middle East, Niner Pharmaceuticals Lead the Competition
February 06, 2025 06:01 ET
|
Research and Markets
Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Middle East & Africa Pharmaceuticals Market, By Country, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ...